{"url_path":"/sec/jsprw/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-056595-index.html","accession_number":"0001213900-26-056595","cik":"0001788028","ticker":"JSPR","issuer_name":"Jasper Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-056595-index.html","primary_entity_key":"0001788028","primary_entity_name":"Jasper Therapeutics, Inc."},"word_count":1140,"has_tables":true,"body_markdown":"jspr-20260331\n\n1\n1\n\nhttp://fasb.org/srt/2026#ChiefExecutiveOfficerMember\n\nfalse\nQ1\n0001788028\n--12-31\n\n0001788028\n\n2026-01-01\n2026-03-31\n\n0001788028\n\n2025-12-31\n2025-12-31\n\n0001788028\n\n2026-03-31\n2026-03-31\n\n0001788028\n\n2025-01-01\n2025-12-31\n\n0001788028\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:MDSAMLMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:SCIDMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:CIndUMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:CIndUMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:AsthmaMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:AsthmaMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:CSUMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:CSUMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:CMOMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:CMOMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:BriquilimabPlatformMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:BriquilimabPlatformMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\n2025-12-31\n\n0001788028\n\n2026-03-31\n\n0001788028\n\nus-gaap:PerformanceSharesMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfPublicWarrantsMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfPublicWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:StockOptionMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:StockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:ValuationOfStockOptionsMember\nsrt:MaximumMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:ValuationOfStockOptionsMember\nsrt:MinimumMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:ValuationOfStockOptionsMember\nsrt:MaximumMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:ValuationOfStockOptionsMember\nsrt:MinimumMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:ValuationOfStockOptionsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:PerformanceBasedStockOptionsMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:PerformanceBasedStockOptionsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:PerformanceShareUnitsPSUsMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:PerformanceShareUnitsPSUsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:PerformanceShareUnitsPSUsMember\n\nResearchanddevelopmentMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:PerformanceShareUnitsPSUsMember\n\nResearchanddevelopmentMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:PerformanceShareUnitsPSUsMember\n\nGeneralandadministrativeMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:PerformanceShareUnitsPSUsMember\n\nGeneralandadministrativeMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:EmployeeStockPurchasePlanMember\n\n2026-03-31\n\n0001788028\n\njspr:EmployeeStockPurchasePlanMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:EmployeeStockPurchasePlanMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:TwoZeroTwoFourESPPMember\njspr:EmployeeStockPurchasePlanMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:PerformanceRestrictedStockUnitsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:PerformanceRestrictedStockUnitsMember\n\n2024-06-01\n2024-06-30\n\n0001788028\n\njspr:PerformanceRestrictedStockUnitsMember\n\n2024-06-30\n\n0001788028\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-12-31\n\n0001788028\n\njspr:PerformanceBasedStockOptionsMember\n\n2026-03-31\n\n0001788028\n\njspr:PerformanceBasedStockOptionsMember\n\n2025-12-31\n2025-12-31\n\n0001788028\n\njspr:PerformanceBasedStockOptionsMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:StockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:StockOptionMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:StockOptionMember\n\n2025-12-31\n2025-12-31\n\n0001788028\n\nus-gaap:StockOptionMember\n\n2025-12-31\n\n0001788028\n\njspr:TwoZeroTwoFourESPPMember\n\n2026-03-31\n\n0001788028\n\njspr:TwoZeroTwoTwoInducementPlanMember\n\n2026-03-31\n\n0001788028\n\njspr:TwoZeroTwoFourESPPMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:TwoZeroOneNinePlanMember\nus-gaap:StockOptionMember\n\n2026-03-31\n\n0001788028\n\njspr:TwoThousandTwentyFourPlanMember\n\n2026-03-31\n\n0001788028\n\njspr:UnderwrittenOfferingsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:UnderwrittenOfferingsMember\n\n2025-09-18\n2025-09-18\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\n2025-03-26\n2025-03-26\n\n0001788028\n\njspr:PublicWarrantsMember\n\n2026-03-31\n\n0001788028\n\njspr:PublicWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001788028\n\njspr:SharesAvailableForGrantUnder2022InducementEquityIncentivePlanMember\n\n2025-12-31\n\n0001788028\n\njspr:SharesAvailableForGrantUnder2022InducementEquityIncentivePlanMember\n\n2026-03-31\n\n0001788028\n\njspr:SharesAvailableForGrantUnderEmployeeStockPurchasePlansMember\n\n2025-12-31\n\n0001788028\n\njspr:SharesAvailableForGrantUnderEmployeeStockPurchasePlansMember\n\n2026-03-31\n\n0001788028\n\njspr:SharesAvailableForGrantUnderEquityIncentivePlansMember\n\n2025-12-31\n\n0001788028\n\njspr:SharesAvailableForGrantUnderEquityIncentivePlansMember\n\n2026-03-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfPreFundedWarrantsMember\n\n2025-12-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfPreFundedWarrantsMember\n\n2026-03-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfCommonStockWarrantsMember\n\n2025-12-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfCommonStockWarrantsMember\n\n2026-03-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfPublicWarrantsMember\n\n2025-12-31\n\n0001788028\n\njspr:SharesIssuableUponExerciseOfPublicWarrantsMember\n\n2026-03-31\n\n0001788028\n\njspr:OutstandingAndIssuedPerformancebasedRestrictedStockUnitsMember\n\n2025-12-31\n\n0001788028\n\njspr:OutstandingAndIssuedRestrictedStockUnitsMember\n\n2025-12-31\n\n0001788028\n\njspr:OutstandingAndIssuedRestrictedStockUnitsMember\n\n2026-03-31\n\n0001788028\n\njspr:OutstandingAndIssuedCommonStockOptionsMember\n\n2025-12-31\n\n0001788028\n\njspr:OutstandingAndIssuedCommonStockOptionsMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:NonvotingCommonStockMember\n\n2026-03-31\n\n0001788028\n\njspr:VotingCommonStockMember\n\n2026-03-31\n\n0001788028\n\n2024-12-01\n2024-12-31\n\n0001788028\n\n2021-03-01\n2021-03-31\n\n0001788028\n\n2025-03-31\n\n0001788028\n\n2025-03-01\n2025-03-31\n\n0001788028\n\njspr:CommonWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:CommonWarrantsMember\n\n2026-03-31\n\n0001788028\n\njspr:PreFundedWarrantsMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:CommonStockMember\njspr:PreFundedWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:CommonWarrantsMember\n\n2025-09-30\n\n0001788028\n\njspr:PreFundedWarrantsMember\n\n2025-09-30\n\n0001788028\n\njspr:September2025OfferingMember\n\n2025-09-01\n2025-09-30\n\n0001788028\n\njspr:TwentyTwentyFourStanfordLicenseAgreementMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:TwentyTwentyFourStanfordLicenseAgreementMember\n\n2026-03-31\n\n0001788028\n\njspr:TwentyTwentyOneStanfordLicenseAgreementMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\njspr:TwentyTwentyOneStanfordLicenseAgreementMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:TwentyTwentyOneStanfordLicenseAgreementMember\n\n2026-03-31\n\n0001788028\n\njspr:CaliforniaInstituteForRegenerativeMedicineMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\n2020-11-01\n2020-11-30\n\n0001788028\n\nus-gaap:ComputerEquipmentMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:ComputerEquipmentMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:FurnitureAndFixturesMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:FurnitureAndFixturesMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:EquipmentMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:EquipmentMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:LeaseholdImprovementsMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:LeaseholdImprovementsMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:MeasurementInputRiskFreeInterestRateMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:MeasurementInputRiskFreeInterestRateMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:MeasurementInputOptionVolatilityMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:MeasurementInputOptionVolatilityMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:MeasurementInputExpectedTermMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:MeasurementInputExpectedTermMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:MeasurementInputSharePriceMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:MeasurementInputSharePriceMember\n\n2026-03-31\n\n0001788028\n\njspr:WarrantLiabilityMember\n\n2026-03-31\n\n0001788028\n\njspr:WarrantLiabilityMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:WarrantLiabilityMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001788028\n\n2024-12-31\n\n0001788028\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0001788028\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001788028\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0001788028\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001788028\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0001788028\n\n2026-05-11\n\n0001788028\n\njspr:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfVotingCommonStockAtAnExercisePriceOf1150Member\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:VotingCommonStockParValue00001PerShareMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:MoneyMarketFundsMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001788028\n\nus-gaap:FairValueMeasurementsRecurringMember\njspr:WarrantLiabilityMember\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001788028\n\njspr:OutstandingAndIssuedPerformancebasedRestrictedStockUnitsMember\n\n2026-03-31\n\n0001788028\n\nus-gaap:NonvotingCommonStockMember\n\n2025-12-31\n\n0001788028\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0001788028\n\nus-gaap:PerformanceSharesMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:SCIDMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:MDSAMLMember\n\n2026-01-01\n2026-03-31\n\n0001788028\n\njspr:ValuationOfStockOptionsMember\n\n2025-01-01\n2025-03-31\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\nutr:sqft\n\njspr:Segment\n\n \n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n \n\nFORM 10-Q\n\n \n\n(Mark One)\n\n☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the quarterly period ended March 31, 2026\n\n \n\nOR\n\n \n\n☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the transition period from ______________\nto ______________\n\n \n\nCommission File Number: 001-39138\n\n \n\nJASPER THERAPEUTICS, INC.\n\n(Exact name of registrant as specified in its\ncharter)\n\n \n\nDelaware 84-2984849\n\n(State or other jurisdiction\nof\n\nincorporation or organization)\n \n(I.R.S. Employer\n\nIdentification No.)\n\n \n\n2200 Bridge Pkwy Suite #102\n\nRedwood City, CA\n 94065\n\n(Address of principal executive\noffices)\n \n(Zip Code)\n\n  \n\n(650) 549-1400\n\n(Registrant’s telephone\nnumber, including area code)\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle\nof each class\n \nTrading\nSymbol(s)\n \nName\nof each exchange on which registered\n\nVoting Common Stock, par value $0.0001 per share JSPR The Nasdaq Stock Market LLC\n\nRedeemable Warrants, each ten warrants exercisable for one share of Voting Common Stock at an exercise price of $115.00 JSPRW The Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒  No  ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒  No  ☐\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act:\n\n \n\nLarge accelerated filer\n☐\nAccelerated filer\n☐\n\nNon-accelerated filer☒Smaller reporting company☒\n\n  Emerging growth company☐\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nAs of May 11, 2026, the number of shares of the registrant’s common stock outstanding was 27,996,819 shares of voting common stock, $0.0001 par value per share, and no shares of non-voting common stock, $0.0001 par value per share.\n\n \n\n \n\n \n\n \n\n \n\nJASPER THERAPEUTICS, INC.\n\nFORM 10-Q FOR THE QUARTERLY PERIOD ENDED\n\nMARCH 31, 2026\n\n \n\nTABLE OF CONTENTS\n\n \n\n \n \nPAGE\n\n \n[PART I. FINANCIAL INFORMATION](#a_001)"}